Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

Emiliano Calvo Aller; Pablo Maroto; Noémi Kreif; José Luis González Larriba; Marta López-Brea; Daniel Castellano; Belén Marti; Silvia Diaz Cerezo

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

Emiliano Calvo Aller, Pablo Maroto, Noémi Kreif, José Luis González Larriba, Marta López-Brea, Daniel Castellano, Belén Marti, Silvia Diaz Cerezo

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	869-877
Number of pages	9
Journal	Clinical and Translational Oncology
Volume	13
Issue number	12
Publication status	Published - 2011

Cite this

@article{66025dc19a054a2bb21536fd48e5333d,

title = "Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain",

author = "Aller, {Emiliano Calvo} and Pablo Maroto and No{\'e}mi Kreif and Larriba, {Jos{\'e} Luis Gonz{\'a}lez} and Marta L{\'o}pez-Brea and Daniel Castellano and Bel{\'e}n Marti and Cerezo, {Silvia Diaz}",

year = "2011",

language = "English",

volume = "13",

pages = "869--877",

journal = "Clinical and Translational Oncology",

publisher = "Springer",

number = "12",

}

TY - JOUR

T1 - Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

AU - Aller, Emiliano Calvo

AU - Maroto, Pablo

AU - Kreif, Noémi

AU - Larriba, José Luis González

AU - López-Brea, Marta

AU - Castellano, Daniel

AU - Marti, Belén

AU - Cerezo, Silvia Diaz

PY - 2011

Y1 - 2011

M3 - Article

VL - 13

SP - 869

EP - 877

JO - Clinical and Translational Oncology

JF - Clinical and Translational Oncology

IS - 12

ER -